The European Technology Platform on Nanomedicine (ETPN) invites its members to partake in a scientific initiative by the FDA/ASTM International Committee E56 on Nanotechnology. The committee is conducting Interlaboratory Studies to assess the precision and bias of liposomal lipid quantitation methods. This initiative offers participating labs the chance to contribute to nanomedicine’s evolution, particularly in relation to standardization and metrological needs. The ETPN also highlights the upcoming launch of the MetrINo project, an innovative European endeavor set to contribute significantly to the Nanomed Europe 2023 conference and the broader nanomedicine landscape.
Dear ETPN members, dear colleagues from the European community of Nanomedicine, we would like to introduce to you the great new ETPN member institutions that have joined us last year! We are proud of this growing community of stakeholders, representing the whole value...
Aug 28, 2023
Post-docs in Nanomedicine at RCSI (Ireland) funded by the NanoCarb & POTENTIAL projects
Mar 29, 2023
PhD position on “Synthesis and characterization of iron carbide nanoparticles” at University of Vienna
Accessible to ETPN members
ETPN premium members